It is being reported that Remdesivir, an antiviral used for the treatment of COVID-19, developed by the biopharmaceutical company Gilead Sciences, may soon be available in oral form. It is originally administered via injection into a vein. The drugs regulator has suggested Remdesivir tablets as a top panel has recommended its emergency use authorisation (EUA). The drug regulator will soon take a decision regarding the same. The COVID drug is currently administered in the country through the intravenous route. Watch the full video to know more about this story and stay updated with the latest news and breaking stories only on Times Now.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting